The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib

It is an exciting time in the field of graft versus host disease (GvHD) research, as new drugs for the treatment of this disease in post-transplant patients have been FDA approved or received breakthr... Author: VJHemOnc Added: 04/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts